244 related articles for article (PubMed ID: 34357837)
1. Curcumin attenuates prostatic hyperplasia caused by inflammation
Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
[TBL] [Abstract][Full Text] [Related]
2. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.
He Y; Ou Z; Chen X; Zu X; Liu L; Li Y; Cao Z; Chen M; Chen Z; Chen H; Qi L; Wang L
Sci Rep; 2016 May; 6():27051. PubMed ID: 27243216
[TBL] [Abstract][Full Text] [Related]
3. Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI.
Zhang B; Chen X; Xie C; Chen Z; Liu Y; Ru F; He Y
Exp Cell Res; 2020 Feb; 387(1):111754. PubMed ID: 31805276
[TBL] [Abstract][Full Text] [Related]
4. Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways.
Wang Z; Chen Z; Li B; Zhang B; Du Y; Liu Y; He Y; Chen X
Pharm Biol; 2020 Dec; 58(1):828-837. PubMed ID: 32866059
[TBL] [Abstract][Full Text] [Related]
5. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
[TBL] [Abstract][Full Text] [Related]
6. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
7. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
Kim Y; Lee EJ; Jang HK; Kim CH; Kim DG; Han JH; Park SM
J Gastroenterol Hepatol; 2016 Jun; 31(6):1220-8. PubMed ID: 26574150
[TBL] [Abstract][Full Text] [Related]
8. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
9. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
Sun XD; Liu XE; Huang DS
Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
[TBL] [Abstract][Full Text] [Related]
10. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
Kim HJ; Jin BR; An HJ
Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565
[TBL] [Abstract][Full Text] [Related]
11. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways.
Zhao HW; Zhang ZF; Chai X; Li GQ; Cui HR; Wang HB; Meng YK; Liu HM; Wang JB; Li RS; Bai ZF; Xiao XH
Int Immunopharmacol; 2016 Jul; 36():249-255. PubMed ID: 27179304
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.
Li YS; Ni SY; Meng Y; Shi XL; Zhao XW; Luo HH; Li X
PLoS One; 2013; 8(10):e76289. PubMed ID: 24155898
[TBL] [Abstract][Full Text] [Related]
13. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effect of aquaporin 5 on estrogen-induced epithelial-mesenchymal transition in prostate epithelial cells.
Fan Y; Song TR; Wei Q; Yang L; Lin T; Feng XB; Wang XD; Huang ZL; Feng SJ
Chin Med J (Engl); 2020 Oct; 134(4):448-455. PubMed ID: 33031138
[TBL] [Abstract][Full Text] [Related]
15. DNMT1 regulates IL-6- and TGF-β1-induced epithelial mesenchymal transition in prostate epithelial cells.
Xu H; Chen Y; Chen Q; Xu H; Wang Y; Yu J; Zhou J; Wang Z; Xu B
Eur J Histochem; 2017 May; 61(2):2775. PubMed ID: 28735516
[TBL] [Abstract][Full Text] [Related]
16. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells.
Dudas PL; Argentieri RL; Farrell FX
Nephrol Dial Transplant; 2009 May; 24(5):1406-16. PubMed ID: 19056781
[TBL] [Abstract][Full Text] [Related]
17. Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cel.
Paramita P; Wardhani BW; Wanandi SI; Louisa M
Asian Pac J Cancer Prev; 2018 May; 19(5):1243-1249. PubMed ID: 29801408
[TBL] [Abstract][Full Text] [Related]
18. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through the Inhibition of Akt/mTOR Pathway.
Zhu FQ; Chen MJ; Zhu M; Zhao RS; Qiu W; Xu X; Liu H; Zhao HW; Yu RJ; Wu XF; Zhang K; Huang H
Biol Pharm Bull; 2017 Jan; 40(1):17-24. PubMed ID: 27829579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]